What can pharmaceutical and nutrition industries learn from each other, and is the historical divide between the two slowly starting to be bridged? In this special edition ahead of CPhI, we look at how the two worlds of pharma and nutrition are colliding.
A new education program by GOED will seek to target primary care practitioners, with the focus on educating the people most likely to influence consumer purchases of the omega-3s.
The Global Organization for EPA and DHA Omega-3s (GOED) continues to commission key studies to support the quality and efficacy of omega-3 fatty acids, with recent meta-analyses of the health benefits starting to impact policy and regulatory conversations.
As growth in probiotics continues to accelerate, the International Probiotics Association is ramping up its regulatory outreach efforts and working on ultimately producing a comprehensive quality guidebook for the probiotic industry, says IPA’s executive...
FDA’s undertaking to create a master list of ‘old dietary ingredients’ that could be sold legally in dietary supplements without first going through the new dietary ingredient notification process likely will fall flat, despite the agency’s best intentions,...
NPA's Dr Daniel Fabricant recaps state of industry at SupplySide West 2017
From finalizing an NDI list to making dietary supplements eligible in welfare programs, Dr Daniel Fabricant of the National Products Association shared his take on the state of the dietary supplements industry.
Professor Alessandra Bordoni is one of the project coordinators of Pathway 27, and leader of the Nutrition Unit at the Campus of FoodScience, University of Bologna. In this NutraIngredients video, she explains the background to Pathway 27, updates us...
With protein seeing continued interest from mainstream consumers, Glanbia Nutritionals has launched ProTherma: a hydrolyzed whey protein that can withstand high temperatures and therefore offer a protein punch in everyday hot beverages.
Following Kerry Group's $220 million (€193m) investment into research and development (R&D) last year, what's next for ingredient innovation at the Irish company? We caught up with the firm's Chief Innovation Officer.
Is there a goal to shoot for when trying to alter consumers’ microbiomes? Researcher Jeff Leach is trying to answer that question with work he is doing among hunter gather groups in Africa.
Analyzing and identifying probiotic strains in a finished product is becoming increasingly crucial as probiotic-infused food, beverages, and supplements climb further into consumer interest.
More studies looking at the link between a human’s microbiome and depression are underway. It’s not entirely a novel connection, according to Dr. Thomas Tompkins, research director at Lallemand Health Solutions, and there’s opportunity for probiotics...
